TCL Archive DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program October 25, 1985
TCL Archive Arzerra Maintenance Therapy Extends PFS In Phase III Trial, Compared to Observation August 29, 2014
TCL Archive Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate March 25, 2011
TCL Archive Troubled Roswell Park Cancer Institute Bets On Recruitment To Regain Its Luster. January 19, 2001
